PDE Antibodies

Santa Cruz Biotechnology features a diverse variety of PDE Antibodies for studying phosphodiesterases, a crucial family of enzymes involved in the regulation of intracellular signaling pathways. PDE Antibodies are validated for multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphodiesterases play a vital role in modulating the levels of cyclic nucleotides, such as cAMP and cGMP, which are key regulators of numerous physiological processes, including cell proliferation, differentiation, and apoptosis. Dysregulation of phosphodiesterase activity has been implicated in various diseases, making PDEs important targets for therapeutic intervention. Understanding the function and regulation of phosphodiesterases is essential for advancing research in cellular signaling and developing new treatment strategies. PDE monoclonal antibodies enable detailed investigation of specific isoforms and their unique functions in different tissues and cellular compartments. Exploring phosphodiesterase regulation and activity patterns helps identify potential therapeutic targets for various medical conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of phosphodiesterase biology and its implications in human health.